PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Health Decisions

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Health Decisions Appoints New CTO to Streamline its HD360° Trial Management Platform - Contract research organization Health Decisions hires Bryan Minihan to boost data integration and flow, providing sponsors and sites with a one-stop web portal for near real-time study information
Health Decisions Appoints New CTO to Streamline its HD360° Trial Management Platform

 

NewswireToday - /newswire/ - Durham, NC, United States, 2010/07/22 - Contract research organization Health Decisions hires Bryan Minihan to boost data integration and flow, providing sponsors and sites with a one-stop web portal for near real-time study information.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Health Decisions, a full-service clinical research organization (CRO) specializing in adaptive solutions for high-efficiency clinical development, has appointed Bryan Minihan as Chief Technology Officer. Minihan will strengthen Health Decisions’ proprietary HD360° technology platform—the fully integrated CTMS, CDMS and web portal that powers the company’s Agile Clinical Development methodology. By expanding the capabilities of HD360°, Health Decisions will provide its sponsors with extended data capture options; a collaborative and secure web-based platform to house near real-time data and metrics; and the ability to acquire timely, actionable insight into operational status.

“Agile Clinical Development is rooted in the ability to track and access the key indicators of study efficiency to allow operational improvements,” said Rick Farris, COO of Health Decisions. “Bryan will provide the expertise and leadership to optimize HD360°, the technological backbone responsible for the collection, assembly, and integration of this constant flow of information. Under his guidance, HD360° will empower our sponsors and study teams with immediate insight into the progress of their studies, allowing early detection and correction of emerging issues before they threaten budget and timeline. HD360° will also reveal opportunities to reallocate monitoring resources or otherwise improve efficiency. We are thrilled to welcome Bryan to the Health Decisions team.”

Minihan brings fifteen years of IT and IS experience to Health Decisions, specializing in agile and traditional project management; usability and interface design; web application development; network engineering; and software architecture. He has built productive, motivated IT teams as CTO for three Internet startup companies, directed GlaxoSmithKline’s global intranet usability and web analytics team, and driven the development of projects and products for Accenture, Intuit, and Cisco.

“Health Decisions has a twenty-year history of deploying cutting-edge technologies that empower sponsors and study teams to take control of their clinical programs,” said Minihan. “I’m excited to be a part of Agile Clinical Development and its mission to fulfill the most basic need of the drug development industry: immediate access to the most accurate, actionable information to make clinical studies safer and more efficient than has previously been possible.”

About Health Decisions
Health Decisions (HealthDec.com) is a global clinical research organization (CRO) committed to helping drug and device companies achieve greater success. Our sponsors rely on us to help them prove the value of their pipelines both faster and with the smartest possible allocation of funds. Through Agile Clinical Development—a strategic combination of adaptive design and adaptive operations—Health Decisions optimizes every facet of clinical research from design protocol to the most detailed day-to-day management, so sponsors can make the most of competitive market opportunities.

Health Decisions is headquartered in Durham, NC, with over twenty years of experience helping sponsors achieve success in Phase I-IV trials across all major therapy areas. For more information, please visit the company's website at the URL accompanying this release.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Health Decisions

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Health Decisions Appoints New CTO to Streamline its HD360° Trial Management Platform

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Katie Hendrick - HealthDec.com 
919-967-1111 x116 khendrick[.]HealthDec.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Health Decisions securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Health Decisions / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers
FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation
Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine
Somatuline® Autogel® 120 Mg Receives Japanese Approval for A New Indication for the Treatment of Gastro-entero-pancreatic Neuroendocrine Tumors
OTC Topical Drugs Market Size will Grow Profitably in the Near Future 2017-2025 Finds PMR
Bioinformatics Market Size to Expand at 20.4% CAGR through 2020 Reports Persistence Market Research
Australia Nitric Acid Market Expected to Reach at Value of $1.3B by 2024 End Says PMR
Commodity Chemicals Market Projected to be Resilient by 2020 Says Persistence Market Research
Cell Expansion Market Set to Garner Staggering Revenues by 2025 Reports PMR
Soft Tissue Sarcoma Treatment Market Revenue Predicted To Go Up by 2025 Finds Persistence Market Research
Persistence Market Research Publishes Biopharmaceutical Membrane Filtration Market Forecast Over 2017-2025
Global Tablet Processing & Packaging Equipment Market to Reach USD 5,268.8 Million by 2022

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  S&A Capital Partner Ltd

Visit  NAKIVO, Inc.





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)